降低风险双侧乳房切除术与BRCA1/2变异携带者死亡率:系统综述与荟萃分析
该系统综述与荟萃分析纳入6项观察性研究、共6135例BRCA1或BRCA2致病变异女性携带者,评估降低风险双侧乳房切除术与全因死亡及乳腺癌特异性死亡的关联。结果显示,该手术与较低的全因死亡率(未调整OR 0.38,95%CI 0.27-0.55;调整后HR 0.37,95%CI 0.23-0.60)和较低的乳腺癌特异性死亡率(OR 0.19,95%CI 0.08-0.47;HR 0.14,95%CI 0.04-0.49)相关。
要点
- 降低风险双侧乳房切除术与BRCA1/2携带者全因死亡率降低相关(调整后HR 0.37)。
- 该手术亦与乳腺癌特异性死亡率降低相关(HR 0.14)。
- 结果基于观察性研究,可支持共享决策讨论。
核心结论
- 在BRCA1或BRCA2致病变异女性携带者中,降低风险双侧乳房切除术与较低的全因死亡率和乳腺癌特异性死亡率相关。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Scopus、CINAHL、Embase和CENTRAL(2025年5月),纳入6项观察性研究,共6135例BRCA1或BRCA2变异女性携带者,排除有乳腺癌病史者。
主要发现
- 降低风险双侧乳房切除术与较低的全因死亡率相关:未调整OR 0.38(95%CI 0.27-0.55,P < .001),调整后HR 0.37(95%CI 0.23-0.60,P < .001)。
- 降低风险双侧乳房切除术与较低的乳腺癌特异性死亡率相关:OR 0.19(95%CI 0.08-0.47,P < .001),HR 0.14(95%CI 0.04-0.49,P = .002)。
- 纳入携带者加权中位年龄为38.0岁,报告年龄范围为15.3至85.3岁。
临床怎么用
- 对于BRCA1或BRCA2致病变异女性携带者,降低风险双侧乳房切除术可作为可能延长生存的干预选择,并用于共享决策讨论。
局限性
- 证据仅来自观察性研究,可能存在未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Risk-reducing bilateral mastectomy reduces the incidence of breast cancer in female carriers of the BRCA pathogenic variants, but its association with mortality remains uncertain. OBJECTIVE: To evaluate the association between risk-reducing bilateral mastectomy and overall and breast cancer-specific mortality in female carriers of BRCA pathogenic variants. DATA SOURCES: PubMed, Scopus, CINAHL, Embase, and CENTRAL were searched in May 2025, with English-language restriction and no date limit. Reference lists of included studies and relevant reviews were also examined. STUDY SELECTION: Eligible studies compared female carriers of BRCA1 and BRCA2 pathogenic variants who underwent risk-reducing bilateral mastectomy with those who did not and reported overall mortality or breast cancer-specific mortality. Studies including patients with a history of breast cancer were excluded. DATA EXTRACTION AND SYNTHESIS: This meta-analysis followed the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Two authors independently performed study selection, data extraction, and risk of bias assessment (using Risk of Bias in Nonrandomized Studies-of Interventions, version 2). Odds ratios (ORs) and hazard ratios (HRs) were pooled using fixed- and random-effects models according to methodological assessment. MAIN OUTCOMES AND MEASURES: Overall and breast cancer-specific mortality. RESULTS: Six observational studies met the inclusion criteria, comprising 6135 carriers of the BRCA1 or BRCA2 variant. Weighted median age at inclusion was 38.0 years, with reported age ranges spanning 15.3 to 85.3 years. Risk-reducing bilateral mastectomy was associated with lower overall mortality in both unadjusted (OR, 0.38; 95% CI, 0.27-0.55; P < .001) and adjusted (HR, 0.37; 95% CI, 0.23-0.60; P < .001) analyses. Breast cancer-specific mortality was also reduced (OR, 0.19; 95% CI, 0.08-0.47; P < .001; HR, 0.14; 95% CI, 0.04-0.49; P = .002). CONCLUSIONS AND RELEVANCE: Risk-reducing bilateral mastectomy was associated with lower overall and breast cancer-specific mortality in carriers of the BRCA variants. These findings support the role of risk-reducing bilateral mastectomy as a potentially life-extending intervention and may inform the shared decision-making discussions in these women.
引用
- O'Reilly C, McGarry JL, Zaborowski AM, et al. Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants: A Systematic Review and Meta-Analysis. JAMA Surg. 2026. PMID: 41499127. doi:10.1001/jamasurg.2025.5929
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。